drugset / Trial / NCT01732263
Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate how much of the study drug SSP-004184 (SPD602) is absorbed by the body and how long it takes to be eliminated from the body in healthy subjects and subjects with mild, moderate, and severe hepatic (liver) impairment compared with subjects with healthy normal liver function.
Timeline
- Start
- 2012-11-09
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DEFERITAZOLE | Small molecule | 50 mg/kg | Oral |
Indications
No indication recorded.